Skip to main content

INFI 25mg (Truseltiq 25 mg)

Generic Name: infigratinib

Pill with imprint INFI 25mg is Gray & White, Capsule-shape and has been identified as Truseltiq 25 mg. It is supplied by BridgeBio Pharma, Inc.

Truseltiq is used in the treatment of biliary tract tumor and belongs to the drug class multikinase inhibitors. Truseltiq 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INFI 25mg

Truseltiq

Generic Name
infigratinib
Imprint
INFI 25mg
Strength
25 mg
Color
Gray & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
BridgeBio Pharma, Inc.
National Drug Code (NDC)
72730-0506

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.